Mechanism of Action for DIFICID® (fidaxomicin)
DIFICID is bactericidal therapy that targets Clostridioides difficile
DIFICID has been shown to be active against most isolates of C. difficile, both in vitro and in clinical infections.
- Macrolide antibiotic bactericidal against C. difficile in vitro, inhibiting RNA synthesis by binding to RNA polymerases
- Acts locally in the gastrointestinal tract